BioLine Launches ISOLATE II, a Precious Find for DNA and RNA Isolation
CINCINNATI--(BUSINESS WIRE)--Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the worldwide release of the high performance ISOLATE II range of nucleic acid purification kits. Based on filter membrane spin column technology with simple bind-wash-elute steps; the new Bioline ISOLATE II kits are designed for fast and efficient isolation of DNA or RNA from a wide range of biological materials. By using ISOLATE II kits, researchers can expect higher yields, higher purity and greater reproducibility when compared to previous generation nucleic acid purification kits.